Macaluso

Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave

Retrieved on: 
Monday, November 22, 2021

Ampio Board member Michael Martino has been appointed as Interim Chairman of the Board of Directors and CEO, effective immediately.

Key Points: 
  • Ampio Board member Michael Martino has been appointed as Interim Chairman of the Board of Directors and CEO, effective immediately.
  • "After careful consideration, I have decided to take a medical leave to focus on my health," said Mike Macaluso.
  • "I feel confident in the ability of Michael Martino, as Interim Chairman and CEO, and our highly skilled management team and employees at Ampio, to lead the Company forward."
  • Commenting on the role, Michael Martino noted "Mike has built a strong team at Ampio, which has made tremendous progress, often during times of significant uncertainty.

Emma Dante's 'The Macaluso Sisters' To Open In LA Theaters Tomorrow

Retrieved on: 
Thursday, August 12, 2021

Emma Dante's adaptation tells the story of how an accidental death in the family turns the lives of five orphaned sisters upside down.

Key Points: 
  • Emma Dante's adaptation tells the story of how an accidental death in the family turns the lives of five orphaned sisters upside down.
  • Emma is available for interviews and reviews are welcome.
  • The Macaluso sisters (Maria, Pinuccia, Lia, Katia and Antonella) are five young, orphaned siblings who live in and work from a shabby rooftop apartment in Palermo, Sicily.
  • "The Macaluso Sisters is a film dealing with the metamorphosis of bodies and objects over a span of seventy years.

Landec Corporation Mourns the Passing of Board Member Charles Macaluso

Retrieved on: 
Wednesday, February 24, 2021

SANTA MARIA, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- It is with great sadness that the Landec Corporation (Nasdaq: LNDC) announces the death of board member Charles Mac Macaluso who passed away on February 22, 2021.

Key Points: 
  • SANTA MARIA, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- It is with great sadness that the Landec Corporation (Nasdaq: LNDC) announces the death of board member Charles Mac Macaluso who passed away on February 22, 2021.
  • Mr. Macaluso served as an independent board member at Landec since October 2019.
  • In addition to his board membership, Mr. Macaluso was a member of the Audit Committee and the Curation Focus Committee.
  • Mr. Macalusos seat on the Landec Corporation board of directors will not be filled at this time.

Darling Ingredients Regretfully Announces The Passing Of Charles Macaluso, A Member Of The Board Since 2002

Retrieved on: 
Tuesday, February 23, 2021

IRVING, Texas, Feb. 23, 2021 /PRNewswire/ --Darling Ingredients Inc. (NYSE: DAR), It is with great sadness that Darling Ingredients announces the passing of Charles Macaluso, longtime board member and friend on February 22, 2021.

Key Points: 
  • IRVING, Texas, Feb. 23, 2021 /PRNewswire/ --Darling Ingredients Inc. (NYSE: DAR), It is with great sadness that Darling Ingredients announces the passing of Charles Macaluso, longtime board member and friend on February 22, 2021.
  • Mr. Macaluso "Mac" joined the Darling board in 2002, where he faithfully served as a director in various capacities.
  • Mac's input and leadership was vital in driving unprecedented growth and success at Darling," said Randall C. Stuewe, Chairman and Chief Executive Officer of Darling Ingredients.
  • "Mac will be greatly missed, and Darling employees and board members wish his family our sincerest condolences during this time."

Pilgrim’s Mourns the Death of Longtime Board Member Charles Macaluso

Retrieved on: 
Tuesday, February 23, 2021

GREELEY, Colo., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Pilgrims Pride Corporation (NASDAQ: PPC) is saddened to announce the passing of longtime board member Charles Macaluso this past weekend.

Key Points: 
  • GREELEY, Colo., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Pilgrims Pride Corporation (NASDAQ: PPC) is saddened to announce the passing of longtime board member Charles Macaluso this past weekend.
  • Macaluso served as an independent board member at Pilgrims since 2009 and was a member of the Audit Committee.
  • On behalf of the Pilgrims Board of Directors, we extend our heartfelt sympathies to the Macaluso family, including his wife Lynn, said Gilberto Tomazoni, Pilgrims chairman of the board.
  • He was a personal friend, respected member of the board and trusted advisor who was deeply committed to Pilgrims.

ITT Names Mark Macaluso Head of Investor Relations

Retrieved on: 
Tuesday, January 5, 2021

ITT Inc. (NYSE: ITT) today announced the appointment of Mark Macaluso as vice president of investor relations.

Key Points: 
  • ITT Inc. (NYSE: ITT) today announced the appointment of Mark Macaluso as vice president of investor relations.
  • In this role, Macaluso will lead the development and execution of ITTs global investor relations strategy and serve as the Companys primary liaison with its shareholders and the investment community.
  • Previously, Macaluso served for five years as vice president of investor relations at Honeywell where he led the companys investor relations strategy for several transformational events.
  • Macaluso was recognized by Institutional Investor for three consecutive years as the top investor relations officer in his sector.

Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th

Retrieved on: 
Monday, November 2, 2020

Attending the conference call from Ampio will be Mr. Michael Macaluso (President and CEO), Dr. David Bar-Or (Director and Founder),Ms. Laura Goldberg (Vice President) and Mr. Daniel Stokely (CFO).

Key Points: 
  • Attending the conference call from Ampio will be Mr. Michael Macaluso (President and CEO), Dr. David Bar-Or (Director and Founder),Ms. Laura Goldberg (Vice President) and Mr. Daniel Stokely (CFO).
  • The business update portionof the callwillconsist of a COVID-19 platform update from Dr. David Bar-Or andan update on the OAK Trial from Laura Goldberg.
  • To ask a question, please dial in to 888-632-3385 (U.S.) or 785-424-1673 (International) and use the Participant Entry Code: 47668.
  • Ampio undertakes no obligation to revise or update these forward-looking statements, whether as a result of new information, future events or otherwise.